Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 363,036Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Pharmathen SA

02 1Supriya Lifescience

03 22care4

04 1Biocon

05 1Cipla

06 2Cipla Medpro South Africa

07 1Hangzhou Jiuyuan Gene Engineering

08 1Hikma Pharmaceuticals

09 1Lupin Ltd

10 1Nanjing King-friend Biochemical Pharmaceutical

11 1Newbury Pharmaceuticals Ab

12 31Novo Nordisk

13 1ORIFARM GROUP AS

14 1Savior Lifetec Corporation

15 3Sun Pharmaceutical Industries Limited

16 1Teva Pharmaceutical Industries

17 1Wanbang Biopharmaceuticals

18 7Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Liraglutide

Brand Name :

Dosage Form : Solution For Injection

Dosage Strength : 6MG/ML

Packaging : Pre-filled Pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Liraglutide

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

03

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name :

Dosage Form : Pen Injector

Dosage Strength : 18MG/3ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

blank

04

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2024-12-23

Application Number : 215503

Regulatory Info : RX

Registration Country : USA

blank

05

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2025-07-22

Application Number : 215421

Regulatory Info : RX

Registration Country : USA

blank

06

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2025-04-02

Application Number : 218115

Regulatory Info : RX

Registration Country : USA

blank

07

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

LIRAGLUTIDE

Brand Name : VICTOZA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2010-01-25

Application Number : 22341

Regulatory Info : RX

Registration Country : USA

blank

08

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

LIRAGLUTIDE

Brand Name : SAXENDA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2014-12-23

Application Number : 206321

Regulatory Info : RX

Registration Country : USA

blank

09

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

INSULIN DEGLUDEC; LIRAGLUTIDE

Brand Name : XULTOPHY 100/3.6

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML;10.8MG/3ML (100 UNITS/ML;3.6MG/ML)

Packaging :

Approval Date :

Application Number : 208583

Regulatory Info :

Registration Country : USA

blank

10

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name : Victoza

Dosage Form : Liraglutide 6Mg/Ml 3Ml 2 Units Parenteral Use

Dosage Strength : 2 pens SC 3 ml 6 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

11

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Insulin Degludec; Liraglutide

Brand Name : Xultophy Insulin Degludec Uml und Liraglutide

Dosage Form : Solution For Injection

Dosage Strength : 600nmol/ml;3.6mg/ml

Packaging :

Approval Date : 12/09/2014

Application Number : 65041

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Insulin Degludec; Liraglutide

Brand Name : Xultophy

Dosage Form : Injectable Solution

Dosage Strength : 100E/ml;3.6mg/ml

Packaging :

Approval Date : 18/09/2014

Application Number : 20130605000014

Regulatory Info : Approved

Registration Country : Sweden

blank

13

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name : Saxenda

Dosage Form : Solution For Injection

Dosage Strength : 6mg/ml

Packaging :

Approval Date : 23/03/2015

Application Number : 20140128000026

Regulatory Info : Approved

Registration Country : Sweden

blank

14

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name : Victoza

Dosage Form : Solution For Injection

Dosage Strength : 6mg/ml

Packaging :

Approval Date : 30/06/2009

Application Number : 20080702000045

Regulatory Info : Approved

Registration Country : Sweden

blank

15

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name : Victoza

Dosage Form : Solution For Injection

Dosage Strength : 6mg/ml

Packaging :

Approval Date : 11/12/2009

Application Number : 59329

Regulatory Info : Allowed

Registration Country : Switzerland

blank

16

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name : Saxenda

Dosage Form : Injectable Solution

Dosage Strength : 6mg/ml

Packaging :

Approval Date : 02/12/2016

Application Number : 65899

Regulatory Info : Allowed

Registration Country : Switzerland

blank

17

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Taiwan

blank

18

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide (Synthetic)

Brand Name : Diavic

Dosage Form : Solution For Injection

Dosage Strength : 6mg/ml

Packaging :

Approval Date : 13/09/2024

Application Number : 20221227000107

Regulatory Info : Approved

Registration Country : Sweden

blank

19

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2025-08-27

Application Number : 214568

Regulatory Info : RX

Registration Country : USA

blank

20

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Liraglutide

Brand Name :

Dosage Form : Injection

Dosage Strength : 18MG/3ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

blank